Castle Biosciences Inc (CSTL)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.04B
Last updated: Nov 17, 2026 at 11:05 AM ET
Castle Biosciences Inc (CSTL) Competitors
The companies most similar to Castle Biosciences are Personalis (PSNL), Fulgent Genetics (FLGT) and Myriad Genetics (MYGN). By market cap, Castle Biosciences ranks 8th of the 13 companies on this page; GRAIL, LLC (GRAL) is the largest at $5.21B. The median P/E of the 3 companies with a P/E is 48.2x.
Peer Comparison
CSTL's ROIC of -5.4% is above the peer median of -12.1%, and its revenue growth of 23.9% is above the median of 9.4%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Castle Biosciences (CSTL) | $1.04B | N/A | 2.7x | -6.1% | -5.4% | 23.9% | 0.00% |
| Personalis Inc (PSNL) | $1.70B | N/A | 20.9x | -147.7% | N/A | 76.6% | 0.00% |
| Fulgent Genetics Inc (FLGT) | $688.98M | N/A | 2.0x | -27.5% | -12.1% | 7.5% | 0.00% |
| Myriad Genetics Inc (MYGN) | $542.92M | N/A | 0.7x | -16.1% | -29.5% | -1.5% | 0.00% |
| NeoGenomics Inc (NEO) | $2.07B | 228.9x | 2.6x | -4.1% | -2.5% | 11.4% | 0.00% |
| Veracyte Inc (VCYT) | $1.96B | 13.3x | 3.3x | 21.8% | 8.2% | 15.1% | 0.00% |
| Opko Health Inc (OPK) | $1.25B | N/A | 2.4x | -22.6% | -6.2% | 15.9% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| GRAIL, LLC (GRAL) | $5.21B | N/A | 29.6x | -243.8% | N/A | 3.7% | 0.00% |
| Adaptive Biotechnologies Corp (ADPT) | $4.70B | N/A | 15.0x | -23.7% | N/A | -10.7% | 0.00% |
| MDxHealth SA (MDXH) | $13.75M | N/A | N/A | -38.3% | -40.5% | -17.2% | 0.00% |
| Solid Biosciences LLC (SLDB) | $763.42M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Beta Bionics, Inc. Common Stock (BBNX) | $892.71M | N/A | 5.6x | -65.3% | -18.0% | 30.3% | 0.00% |
| Peer median | $1.48B | 48.2x | 4.4x | -23.1% | -12.1% | 9.4% | 0.00% |
Similar Companies
These are the 12 companies most similar to Castle Biosciences, ranked by how closely their business, size, sector and industry match. The largest group, 10 of the 12, is in Diagnostics & Research; the other 2 span 2 industries.
| Company | About | Peers |
|---|---|---|
| Personalis Inc (PSNL)Diagnostics & Research | Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California. | PSNL competitors |
| Fulgent Genetics Inc (FLGT)Diagnostics & Research | Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. | FLGT competitors |
| Myriad Genetics Inc (MYGN)Diagnostics & Research | Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized... | MYGN competitors |
| NeoGenomics Inc (NEO)Diagnostics & Research | NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. | NEO competitors |
| Veracyte Inc (VCYT)Diagnostics & Research | Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California. | VCYT competitors |
| Opko Health Inc (OPK)Diagnostics & Research | OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico... | OPK competitors |
| CareDx Inc (CDNA)Diagnostics & Research | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
| GRAIL, LLC (GRAL)Diagnostics & Research | GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics... | GRAL competitors |
| Adaptive Biotechnologies Corp (ADPT)Diagnostics & Research | Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. | ADPT competitors |
| MDxHealth SA (MDXH)Diagnostics & Research | MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers. | MDXH competitors |
| Solid Biosciences LLC (SLDB)Biotechnology | Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. | SLDB competitors |
| Beta Bionics, Inc. Common Stock (BBNX)Medical Devices | Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development... | BBNX competitors |
Frequently Asked Questions About CSTL
Who are Castle Biosciences' main competitors?
The companies most similar to Castle Biosciences include Personalis (PSNL), Fulgent Genetics (FLGT), Myriad Genetics (MYGN), NeoGenomics (NEO) and Veracyte (VCYT), listed from the closest match.
Who is Castle Biosciences' biggest competitor?
GRAIL, LLC (GRAL) is the largest of the similar companies at $5.21B; Personalis (PSNL) is the closest match by business profile, size, sector and industry.
How does CSTL stock compare with its competitors?
CSTL's P/S is 2.7x against a peer median of 4.4x; its net margin is -6.1% against a peer median of -23.1%.
Which of Castle Biosciences' competitors pays a higher dividend?
Castle Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Castle Biosciences bigger than its competitors?
No. Castle Biosciences is 8th by market cap among the 13 companies on this page; the largest is GRAIL, LLC (GRAL) at $5.21B.
CSTL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts